Continuous Infusion Ketamine for Adjunctive Sedation in Medical Intensive Care Unit Patients: A Case Series
Journal Title: Enliven: Journal of Anesthesiology and Critical Care Medicine - Year 2015, Vol 2, Issue 5
Abstract
Ketamine has been rarely described for use in critically ill patients. We describe our institutional experience using continuous infusion ketamine for sedation. This was a retrospective chart review of patients admitted to the medical intensive care units (MICUs). An informatics query of patients who received continuous infusion ketamine between 1/1/2010 and 7/1/2012 was conducted. Mechanically ventilated patients in the MICU who received continuous infusion ketamine were included. Twelve patients met criteria. Mean age was 41; 60% were Caucasian and 60% were female. Six patients were admitted for pneumonia, three for asthma exacerbation. Median duration of ketamine therapy was 1.57 days. Median minimum and maximum rates were 0.24mg/kg/hr and 0.83mg/kg/hr. The maximum documented dose used was 2.8mg/kg/hr. The ketamine infusion was discontinued secondary to tachycardia or hypertension in two patients. No patient who received concomitant benzodiazepines experienced hemodynamic changes prompting ketamine cessation. Median maximum SBP, DBP, and HR while on ketamine were 154, 96 and 121, respectively. No further adverse events were identified. Five of the patients had decreases in concomitant sedative and analgesic doses while five had increases. Continuous infusion ketamine can safely be used for adjunctive sedation/analgesia in mechanically ventilated MICU patients. Larger trials are needed to further define optimal dosing and confirm safety.
Authors and Affiliations
B. Whitman Craig, Rhodes Heather, R. Tellor Bethany, B. Hampton Nicholas
Keywords
Related Articles
- EP ID EP618700
- DOI -
- Views 143
- Downloads 0
Cuffed Endotracheal Tube Size and Leakage in Pediatric Tracheal Models
Object: Cuffed endotracheal tubes are increasingly used in pediatric patients in the hope that they can reduce air leakage and tube size mismatch by just inflating the cuff. Authors compared influence of various tube siz...
Magnesium on Blockage of Nuclear Factor-B Activation at Ventilator-Induced Lung Injury: Random Trial
Rationale The mechanical ventilation may aggravate the severe acute lung injury and trigger a systemic inflammatory response. The pathophysiology evolves Biotrauma, meaning that the over distension and the cyclical openi...
Reversal with Sugammadex in the Absence of Neuromuscular Monitoring
Sugammadex provides rapid and reliable recovery of neuromuscular (NM) function from rocuronium or vecuronium-induced NMblockade than neostigmine. The dose of sugammadex, ranges from 2 to 16 mg/kg, is adequately matched w...
Left Ventricular Assist Device and Resident Cardiac Stem Cells in Heart Failure: Human Heart's Potential Matter
Heart disease is the leading cause of mortality in Western countries, accounting for 17.3 million deaths per year. The impact of cardiovascular diseases is influenced by the ability to treat and assist patients surviving...
Transfusion of Blood Products is not Associated with Intensive Care Unit-Acquired Weakness when Corrected for Illness Severity
Introduction Intensive Care Unit-acquired weakness (ICU-AW) is a common and severe complication of intensive care admission. We studied the effect of blood product transfusion (possibly a modifiable risk factor) on ICU-A...